Retention in methadone maintenance treatment programs, Connecticut and Massachusetts, 1990 – 1993

Journal of Psychoactive Drugs

Volumn 28, Issue 3, 1996, Pages 259-265

  MacGowan, Robin J ^a   Swanson, Nancy M ^b   Brackbill, Robert M ^a   Rugg, Deborah L ^a   Barker, Thomas ^c   Molde, Susan ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^d APT Foundation ^*  (United States)

Author keywords

Connecticut; HIV prevention; Massachusetts; Methadone maintenance; Retention

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE;

ADULT; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NARCOTIC DEPENDENCE; PATIENT COMPLIANCE; PATIENT SELECTION; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES;

EID: 0029793032     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.1996.10472487     Document Type: Article

References (29)

1. Abdul-Quader, A.S.; Freidman, S.R.; Des Jarlais, D.; Marmor, M.M.; Maslansky, R. & Bartelme, S. 1987. Methadone maintenance and behavior by intravenous drug users that can transmit HIV. Contemporary Drug Problems Fall:425-34.
2. Ball, J.; Lange, R.W.; Myers, C.R & Freidman, S.R. 1988. Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior29 (3): 214-26.
3. Caplehom, J.R. & Bell, J. 1991. Methadone dosage and retention of patients in maintenance treatment. Medical Journal of Australia154:195-99.
4. Caplehom, J.R.; Bell, J.; Kleinbaum, D.G. & Gebski, V.J. 1993. Methadone dose and heroin use during maintenance treatment.Addictions88:119-24.
5. Caplehom, J.R.; McNeil, D.R. & Kleinbaum, D.G. 1993. Clinic policy and retention in methadone maintenance. International Journal of the Addictions28:73-90.
6. Centers for Disease Control and Prevention (CDC). 1994. HIVIAIDS Surveillance Report5 (4): 8.
7. Cooper, J R. 1989. Methadone treatment and acquired immunodeficiency syndrome.Journal of the American Medical Association 262(12): 1664-668.
8. Crabtree, B. & Miller, W.L. 1992. Doing qualitative research. Research Methods for Primary Care: Volume 3.Newbury Park, California: Sage.
9. D’Aunno, T. & Vaughn, T. 1992. Variations in methadone treatment practices. Results from a national study. Journal of the American Medical Association267 (2): 253-58.
10. Dole, V.; Nyswander, M.; Des Jarlais, D. & Joseph, H. 1982. Performance-based rating of methadone maintenance programs. New England Journal of Medicine306 (3): 169-72.
11. Farley, T.A.; Cartter, M.L.; Wassell, J.T. & Hadler, J.L. 1992. Predictors of outcome in methadone programs: Effect of HIV counseling and testing. AIDS6:115-21.
12. Hartel, D.M.; Schoenbaum, E.E.; Selwyn, P.A.; Klein, J.; Davenny, K.; Klein, R.S. & Friedland, G.H. 1995. Heroin use during methadone maintenance treatment: The importance of methadone dose and cocaine use. American Journal of Public Health85 (1): 83-88.
13. McLellan, T.A. 1983. Patient characteristics associated with outcome. In: J.R. Cooper, F. Altman, B.S. Brown & D. Czechowicz (Eds.)Research on the Treatment of Narcotic Addiction: State of the Art. DHHS publication ADM 83-1281. Rockville, Maryland: National Institute on Drag Abuse.
14. Miles, M.B. & Huberman, A.M. 1984. Qualitative Data Analysis: A Sourcebook of New Methods. Newbury Paik, California: Sage.
15. Moolchan, E.T. & Hoffman, J.A. 1994. Phases of treatment: A practical approach to methadone maintenance treatment. International Journal of the Addictions29 (2): 135-60.
16. National Commission on AIDS. 1991. The Twin Epidemics of Substance Abuse and HIV. Washington, D.C.: National Commission on AIDS.
17. Payte, J.T. & Khuri, E.T. 1993. Principles of methadone dose determination. State Methadone Maintenance Treatment Guidelines: Treatment Improvement Protocol Series. DHHS publication (SMA) 93-1991. Rockville, Maryland: Center for Substance Abuse Treatment.
18. Rugg, D.L.; MacGowan, R.J.; Stark, K.A. & Swanson, N.M. 1991. Evaluating the CDC program for HIV counseling and testing. Public Health Reports106:708-13.
19. SAS Institute Inc. 1990. SAS Procedures Guide Version 6.3rd ed. Cary. North Carolina: SAS Institute Inc.
20. SAS Institute Inc. 1989. SASISTAT User's Guide Version 6. 4th ed. Vol. 2. Cary, North Carolina: SAS Institute Inc.
21. Seidel, J. V.; Kjolseth, R. & Seymore, E. “THE ETHNOGRAPH" (Version 3-4) 1988-90. Littleton, Colorado: Qualis Research Associates.
22. Simpson, D. 1981. Treatment for drag abuse: Follow-up outcomes and length of time spent. Archives of General Psychiatry38:875-80.
23. Sorenson, J.L.; Batki, S.L.; Coates, C. & Gibson, D.R. 1988. Methadone maintenance as AIDS prevention: Efficacy three months into treatment. Paper presented at the American Public Health Association Meeting, Boston.
24. Strain, E C.; Stitzer, M L.; Liebson, I.A. & Bigelow, G.E. 1993. Dose-response effect of methadone in the treatment of opioid dependence. Annals of Internal Medicine119 (1): 23-27.
25. Swanson, N.M.; Patton, C.; McNamara, R.; Forsythe, J. & Lasch, K. 1994. HIV Counseling andTesling Evaluation Study: Ethnographic Component Final Report. Unpublished data.
26. Waldorf, D. 1983. Natural recovery from opioid addiction: Some social-psychological processes of untreated recovery. Journal of Drug Issues13 (2): 237-80.
27. Weddington, W.W.; Haertzen, C.A.; Hess, J.M. & Brown, B.S. 1991. Psychological reactions and retention by cocaine addicts during treatment according to HIV serostatus: A matched-control study. American Journal of Drug and Alcohol Abuse17 (3): 355-68.
28. Winick, C. 1962. Maturing out of narcotic addiction. Bulletin of Narcotics14:1-7.
29. Wodak, A. & Moss, A. 1990. HIV and injection drug users: From epidemiology to public health. AIDS4(suppl.): S105-S109.